TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/2/23 16:37 | 9/28/23 | RNAZ | Transcode Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dudley Robert Michael | MA | DO | CEO | P | 50 | 0.5100 | 0 | 98 | 119 | 180 | D | ||||||||||||||
6/22/23 18:23 | 6/20/23 | RNAZ | Transcode Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dudley Robert Michael | MA | DO | CEO | P.m | 49 | 2.62 | 0 | 19 | 29 | 82 | D | ||||||||||||||
6/14/23 16:16 | 6/9/23 | RNAZ | Transcode Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dudley Robert Michael | MA | DO | CEO | P.a | 52 | 2.76 | 0 | 19 | 45 | 61 | D | ||||||||||||||
6/13/23 16:16 | 6/9/23 | RNAZ | Transcode Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dudley Robert Michael | MA | DO | CEO | P | 52 | 2.76 | 0 | 19 | 2 | 912 | D | ||||||||||||||
9/16/22 18:44 | 9/14/22 | RNAZ | Transcode Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dudley Robert Michael | MA | DOT | CEO | P | 23 | 1.15 | 0 | 20 | 2 | 893 | D | ||||||||||||||
6/1/22 16:01 | 5/27/22 | RNAZ | Transcode Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dudley Robert Michael | MA | DOT | CEO | P.m | 55 | 1.85 | 0 | 30 | 4 | 873 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |